Chris Collins Lectures
Chris Collins was made an Honorary Member of EBSA for his outstanding contribution to biosafety at the Vienna meeting of EBSA in March 2002. In further recognition of his extraordinary achievements the keynote lecture at the annual EBSA conference has been named, since 2003, in his memory.
|Bucharest 2019||Thinking Outside the Biosafety Box: BSL-2 Laboratory Design and Outfitting Safety and Health Pointers
Felix Gmünder, Global Biosafety Consultant, Basler & Hofmann, Switzerland
|Copenhagen 2018||We All Have a Bucket - Applying High Reliability Principles to Biosafety.
Tim Trevan, Chrome Biorisk Management, United States
|Madrid 2017||WHO GAP III roadmap to compliance for poliovirus-essential facilities
Toon De Kesel, Biorisk Expert, Febris, Belgium
|Lille 2016||WHO biosafety manual revision - concept and consequences
Dr. Kazunobu Kojima, World Heath Organization (WHO)
|Vienna 2015||ustainable improvement of biosafety standards in low resource settings - a global challenge with many players
H. Sheeley, Public Health England, Salisbury/UK
U. Müller-Doblies, Epibiosafe, Knaphill/UK
|Ghent 2014||Biosafety and the global community - What's next?
J. Welch, Elizabeth R. Griffin Research Foundation, Kingsport, TN/USA
|Basel 2013||My experiences with laboratory incidents and acquired infections: what goes wrong and how do we handle them?
A. Della-Porta, Biosecurity and Biocontainment International Consultants Pty. Ltd,
Chasing: influenza virus from 1918 Spanish flu exhumations to infection of volunteers in quarantine
|Estoril 2011||Aerosols to all that! From Pasteur to PCR, an alternative history of biosafety
A. Bennett, Health Protection Agency, Salisbury/UK
|Ljubljana 2010||Determinants of virulence in zoonotic and pandemic influenza viruses
Sander Herfst, Erasmus Medical Center, Rotterdam/NL
|Stockholm 2009||Coping with biosafety in extreme filed conditions
Herwig Leirs, Universiteit Antwerpen/Belgium
|Florence 2008||Emerging Zoonosis
Malcom Bennett, Liverpool University, United Kingdom
|Heidelberg 2007||The Genetic modification of blood forming stem cells
Christof von Kalle, Director National Center on Tumour Diseases, Heidelberg, Germany
|The Hague 2006||Vaccine development for SARS, influenza and smallpox
Albert Osterhaus, Erasmus MC, The Netherlands
|Barcelona 2005||Biological Safety Concepts of Genetically Modified Live Vaccines
Joachim Frey - University of Bern Institute for Veterinary Bacteriology, Bern, Switzerland
|Prague 2004||Investigation of 1918 Spanish flu using permafrost burials and pathology lung blocks
Dr. Rod Daniels, National Institute for Medical Research, London, UK
Is our Focus to be more Biosafety or Biosecurity in the Era of Bio-Terrorism?